| 2025年中报 | 2024年年报 | 2024年中报 | |
|---|---|---|---|
| 营业收入(元) | |||
| 大消费类(元) | 2,161,180.21 | 5,925,359.79 | 3,527,661.72 |
| 固体类(元) | 14,202,523.72 | 26,763,850.89 | 10,312,139.77 |
| 客户肽(元) | 4,623,455.17 | 6,177,448.32 | 2,563,042.13 |
| 器械类(元) | - | 1,306,318.61 | 656,761.08 |
| 原料药(元) | 171,976,999.19 | 259,895,285.34 | 113,113,719.47 |
| 制剂(元) | 339,625,221.00 | 247,133,876.44 | 102,697,238.64 |
| 其他(补充)(元) | 16,852,727.50 | - | 22,850,011.33 |
| 营业成本(元) | |||
| 大消费类(元) | 1,287,140.90 | 3,060,958.95 | 1,758,502.87 |
| 固体类(元) | 13,052,073.11 | 22,397,454.77 | 8,192,781.96 |
| 客户肽(元) | 1,341,842.14 | 1,856,881.11 | 783,997.76 |
| 器械类(元) | - | 2,296,712.11 | 1,110,032.59 |
| 原料药(元) | 39,863,431.16 | 67,689,741.07 | 30,474,694.95 |
| 制剂(元) | 143,931,315.52 | 128,104,388.30 | 48,653,861.71 |
| 其他(补充)(元) | 6,768,058.49 | - | 11,094,319.40 |
| 毛利(元) | |||
| 大消费类(元) | 874,039.31 | 2,864,400.84 | 1,769,158.85 |
| 固体类(元) | 1,150,450.61 | 4,366,396.12 | 2,119,357.81 |
| 客户肽(元) | 3,281,613.03 | 4,320,567.21 | 1,779,044.37 |
| 器械类(元) | - | -990,393.50 | -453,271.51 |
| 原料药(元) | 132,113,568.03 | 192,205,544.27 | 82,639,024.52 |
| 制剂(元) | 195,693,905.48 | 119,029,488.14 | 54,043,376.93 |
| 其他(补充)(元) | 10,084,669.01 | - | 11,755,691.93 |
| 毛利率(%) | |||
| 大消费类(%) | 40.44 | 48.34 | 50.15 |
| 固体类(%) | 8.10 | 16.31 | 20.55 |
| 客户肽(%) | 70.98 | 69.94 | 69.41 |
| 器械类(%) | - | -75.82 | -69.02 |
| 原料药(%) | 76.82 | 73.95 | 73.06 |
| 制剂(%) | 57.62 | 48.16 | 52.62 |
| 其他(补充)(%) | 59.84 | - | 51.45 |
| 收入构成(%) | |||
| 大消费类(%) | 0.39 | 1.08 | 1.38 |
| 固体类(%) | 2.58 | 4.89 | 4.03 |
| 客户肽(%) | 0.84 | 1.13 | 1.00 |
| 器械类(%) | - | 0.24 | 0.26 |
| 原料药(%) | 31.30 | 47.50 | 44.23 |
| 制剂(%) | 61.81 | 45.16 | 40.16 |
| 其他(补充)(%) | 3.07 | - | 8.94 |
| 毛利构成(%) | |||
| 大消费类(%) | 0.25 | 0.89 | 1.15 |
| 固体类(%) | 0.34 | 1.36 | 1.38 |
| 客户肽(%) | 0.96 | 1.34 | 1.16 |
| 器械类(%) | - | -0.31 | -0.29 |
| 原料药(%) | 38.49 | 59.73 | 53.78 |
| 制剂(%) | 57.02 | 36.99 | 35.17 |
| 其他(补充)(%) | 2.94 | - | 7.65 |